HEMPBRI
DEAD

Serial Number

97273282

Owner

Pysarzhevskyi, Oleh

Attorney

Elias Hantula

First Use Date

Mar 25, 2019

Filing Date

Feb 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HEMPBRI Trademark

Serial Number: 97273282

HEMPBRI is a trademark filed by Pysarzhevskyi, Oleh on February 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Pysarzhevskyi, Oleh (2 trademarks)

Hasina, building 125, Koniukhiv
Stryiskyi 82436 , UA

Entity Type: 01

Trademark Details

Filing Date

February 18, 2022

Registration Date

Not Registered

First Use Anywhere

March 25, 2019

First Use in Commerce

March 25, 2019

Goods & Services

Disinfectants; Fungicides; Herbicides; Dietetic beverages adapted for medical purposes; Dietetic beverages adapted for medical use; Dietetic confectionery adapted for medical purposes; Dietetic foods adapted for medical use; Dietetic foods and beverages adapted for medical use; Dietetic infusions for medical use; Dietetic preparations adapted for medical purposes; Dietetic sugar for medical use; Dietetic sugar substitutes for medical use; Food for babies; Material for stopping teeth, dental wax; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for skin care for animals; Plasters for medical purposes; Preparations for destroying vermin; Sanitary preparations for medical purposes; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations, namely, antioxidants; Veterinary preparations, namely, pain relief medication; Amino acid preparations for veterinary purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-epileptic pharmaceutical preparations; Bacterial preparations for veterinary purposes; Balms for pharmaceutical purposes; Bicarbonate of soda for pharmaceutical purposes; Cardiovascular pharmaceutical preparations; Diagnostic preparations for veterinary purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Effervescent analgesic pharmaceutical preparations; Enzyme preparations for veterinary purposes; Medical plasters

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 27, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 27, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 27, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 10, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 24, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2022 NWOS
NEW APPLICATION ENTERED
Feb 22, 2022 NWAP